Status:
COMPLETED
Surfactant Derived Protocol in Heart Failure
Lead Sponsor:
Centro Cardiologico Monzino
Collaborating Sponsors:
Ospedale San Luca, Istituto Auxologico Italiano, Milano
Conditions:
Heart Failure
Eligibility:
All Genders
Phase:
NA
Brief Summary
Pulmonary surfactant is a highly surface-active lipoprotein complex that lines the alveoli and terminal airways, reducing surface tension and preventing alveolar collapse at the end of expiration. It ...
Detailed Description
Pulmonary surfactant is a highly surface-active lipoprotein complex that forms a thin film lining the alveolar and terminal airway surfaces. Its primary physiological function is to reduce surface ten...
Eligibility Criteria
Inclusion
- Heart failure diagnosis
- Left ventricular ejection fraction \<40%
- Stable clinical condition
Exclusion
- Relevant comorbidities
- usual contraindications to cardiopulmonary testing.
Key Trial Info
Start Date :
May 6 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
471 Patients enrolled
Trial Details
Trial ID
NCT06896461
Start Date
May 6 2016
End Date
December 31 2024
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Cardiologico Monzino
Milan, Italy, Italy, 20138